Related Experiment Video
Updated: Aug 3, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
PTBP2-Mediated Alternative Splicing of IRF9 Controls Tumor-Associated Monocyte/Macrophage Chemotaxis and
Jue Tang1, Jing He1, Huiqin Guo1,2
1Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China.
Abstract:
The recurrence and metastasis of children with mediastinal neuroblastoma (NB) are also occurred after surgery, chemotherapy, or radiotherapy. Strategies targeting the tumor microenvironment have been reported to improve survival; however, thorough investigations of monocytes and tumor-associated macrophages (Mϕs) with specialized functions in NB are still lacking. Our data first demonstrated polypyrimidine tract binding protein 2 (PTBP2) as a possible identifier in patients with mediastinal NB screened by proteomic profiling and that PTBP2 predicted good outcomes. Functional studies revealed that PTBP2 in NB cells induced the chemotactic activity and repolarization of tumor-associated monocytes and Mϕs, which, in turn, inhibited NB growth and dissemination. Mechanistically, PTBP2 prevents interferon regulatory factor 9 alternative splicing and upregulates signal transducers and activators of transcription 1 to stimulate C-C motif chemokine ligand 5 (CCL5) and interferon-stimulated gene factor-dependent type I interferon secretion, to induce monocyte/Mϕs chemotaxis, and to sustain monocytes in a proinflammatory phenotype. Our study defined a critical event of PTBP2-induced monocytes/Mϕs in NB progression and revealed that RNA splicing occurred by PTBP2 benefits immune compartmentalization between NB cells and monocytes. This work revealed the pathological and biological role of PTBP2 in NB development and indicates that PTBP2-induced RNA splicing benefits immune compartmentalization and predicted a favorable prognosis in mediastinal NB.
Insights
Polypyrimidine tract binding protein 2 (PTBP2) in neuroblastoma (NB) cells attracts monocytes and macrophages, inhibiting tumor growth. This PTBP2-induced immune response predicts a favorable prognosis in mediastinal NB.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Mediastinal neuroblastoma (NB) recurrence and metastasis remain significant challenges post-treatment.
- Tumor microenvironment modulation shows promise, yet the roles of monocytes and macrophages in NB are underexplored.
Purpose of the Study:
- To investigate the role of polypyrimidine tract binding protein 2 (PTBP2) in mediastinal NB.
- To elucidate the mechanisms by which PTBP2 influences the tumor microenvironment, specifically monocytes and macrophages.
Main Methods:
- Proteomic profiling to identify potential biomarkers in mediastinal NB.
- Functional studies assessing the impact of PTBP2 on monocyte/macrophage activity and NB progression.
- Mechanistic investigations involving RNA splicing, interferon signaling, and chemokine secretion.
Main Results:
- PTBP2 was identified as a potential biomarker in mediastinal NB, correlating with good outcomes.
- PTBP2 expression in NB cells promoted monocyte and macrophage chemotaxis and repolarization, inhibiting tumor growth and metastasis.
- PTBP2 was found to regulate interferon regulatory factor 9 splicing and enhance type I interferon secretion via STAT1 and CCL5, driving monocyte/macrophage recruitment and maintaining a proinflammatory phenotype.
Conclusions:
- PTBP2 plays a critical role in modulating the immune microenvironment in NB by influencing monocyte and macrophage functions.
- PTBP2-mediated RNA splicing enhances immune compartmentalization between NB cells and monocytes, contributing to a favorable prognosis.
- PTBP2 represents a potential therapeutic target and prognostic marker for mediastinal neuroblastoma.
More Related Videos
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
piRNA - Piwi-interacting RNAs
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

